While we have concentrated the most current key reports just below, COVID-19 announcements, analysis and commentary will be found throughout this issue, in all sections.
Beyond the considerable continuing coverage in the global general media:
Daily WHO situation reports here: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
WHO Coronavirus disease (COVID-2019) daily press briefings here: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/press-briefings
Public Health Emergency of International Concern (PHEIC)
Situation report – 33 [WHO]
Novel Coronavirus (COVID-19)
22 February 2020
SITUATION IN NUMBERS
Globally :: 77,794 laboratory-confirmed [599 new]
[Week ago: 49,053 laboratory-confirmed [2056 new]]
China :: 76,392 laboratory-confirmed [397 new]
:: 2,348 deaths [109 new]
Outside of China
:: 1,402 laboratory-confirmed [58 new]
:: 28 countries
:: 11 deaths [1 new]
WHO RISK ASSESSMENT
China – Very High
Regional Level – High
Global Level – High
:: Two new countries (Lebanon and Israel) reported cases of COVID-19 in the past 24 hours.
:: The role of environmental contamination in the transmission of COVID-19 is not yet clear. On 18 February, a new protocol entitled “Surface sampling of coronavirus disease (COVID-19): A practical “how to” protocol for health care and public health professionals” was published. This protocol was designed to determine viable virus presence and persistence on fomites in various locations where a COVID-19 patient is receiving care or isolated, and to understand how fomites may play a role in the transmission of the virus.
:: The WHO Director-General briefed the emergency ministerial meeting on COVID-19 organized by the African Union and the Africa Centres for Disease Control and Prevention. Details can be found here.
National Health Commission of the People’s Republic of China
Selected News & Announcements
Feb 22: Daily briefing on novel coronavirus cases in China
On Feb 21, 31 provincial-level regions on the Chinese mainland as well as the Xinjiang Production and Construction Corps reported 397 new cases of confirmed infections, 1,361 new cases of suspected infections, and 109 deaths.
[See Emergencies above for detail]
China races to develop vaccines against coronavirus
BEIJING — Chinese scientists are racing to develop vaccines against the novel coronavirus by adopting five technological approaches, a senior National Health Commission official said on Feb 21.
“Some projects have entered the stage of animal testing,” Zeng Yixin, deputy director of the commission, told a news conference on China’s fight against the novel coronavirus outbreak.
“Under the premise of ensuring safety, effectiveness and accessibility (of vaccines), (we) foresee that as soon as from April to May this year some vaccines could enter clinical trials, or under specific conditions, could be applied for emergency use,” he said.
“Our goal is that if required by the outbreak situation, the emergency use of vaccines, as well as the emergency review and approval process, can be activated in accordance with laws,” the official said.
Johnson & Johnson to Expand Partnership with U.S. Department of Health & Human Services to Accelerate the Discovery of Potential COVID-19 Treatments
NEW BRUNSWICK, N.J., Feb. 18, 2020 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced that its Janssen Pharmaceutical Companies will expand its existing partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health & Human Services, to seek treatment solutions for COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2 (also known as 2019-nCoV). This latest collaboration will enhance Janssen’s ongoing work with global partners to screen a library of existing antiviral molecules, with the aim of identifying compounds with promising antiviral activity against SARS-CoV-2.
The expanded partnership with BARDA builds on Johnson & Johnson’s multipronged response to the COVID-19 outbreak. These efforts, in addition to the ongoing development of a potential vaccine candidate, bring hope of finding a solution against COVID-19 for communities in greatest need in China and around the world…